<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">Tsinghua University</th>
</tr>
<tr>
<td class="infobox-image" colspan="2">
<em>Logo placeholder</em>
</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Beijing, China</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Research University</td>
</tr>
<tr>
<td class="label">Established</td>
<td>1911</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://www.tsinghua.edu.cn/" target="_blank">https://www.tsinghua.edu.cn/</a></td>
</tr>
<tr>
<td class="label">Focus Areas</td>
<td>[Alzheimer's Disease](/diseases/alzheimers), [Parkinson's Disease](/diseases/parkinsons-disease), [Neuroscience](/mechanisms), [Neuroinflammation](/mechanisms/neuroinflammation)</td>
</tr>
<tr>
<td class="label">Departments</td>
<td>School of Medicine, Institute for Precision Medicine, School of Life Sciences</td>
</tr>
<tr>
<td class="label">Rankings</td>
<td>Top 20 globally (QS), #1 in China</td>
</tr>
</table>
<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">Tsinghua University</th>
</tr>
<tr>
<td class="infobox-image" colspan="2">
<em>Logo placeholder</em>
</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Beijing, China</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Research University</td>
</tr>
<tr>
<td class="label">Established</td>
<td>1911</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://www.tsinghua.edu.cn/" target="_blank">https://www.tsinghua.edu.cn/</a></td>
</tr>
<tr>
<td class="label">Focus Areas</td>
<td>[Alzheimer's Disease](/diseases/alzheimers), [Parkinson's Disease](/diseases/parkinsons-disease), [Neuroscience](/mechanisms), [Neuroinflammation](/mechanisms/neuroinflammation)</td>
</tr>
<tr>
<td class="label">Departments</td>
<td>School of Medicine, Institute for Precision Medicine, School of Life Sciences</td>
</tr>
<tr>
<td class="label">Rankings</td>
<td>Top 20 globally (QS), #1 in China</td>
</tr>
</table>
Tsinghua University (清华大学) is China's leading research university, located in Beijing and founded in 1911[@tsinghua2026]. Often referred to as "the MIT of China," Tsinghua has established particular excellence in science, engineering, and medicine. The university has developed strong programs in neuroscience and neurodegenerative disease research, with focus on [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), and [neuroinflammation](/mechanisms/neuroinflammation).
Tsinghua maintains several research centers dedicated to neuroscience and neurodegeneration, including the School of Medicine, Institute for Precision Medicine, and School of Life Sciences["@school2026"]. These centers leverage Tsinghua's strengths in engineering and basic science to advance understanding of neurological disorders.
Tsinghua University was established in 1911 as Tsinghua College and has grown into one of China's most prestigious universities. The School of Medicine was re-established in 2001 to advance biomedical research and education.
The Institute for Precision Medicine, established in 2015, focuses on applying cutting-edge technologies to understand and treat human diseases, including neurodegenerative disorders.
Tsinghua's journey from a foreign language school to one of the world's leading research universities represents China's broader emergence as a global scientific powerhouse. The university's commitment to interdisciplinary research has made it a hub for neuroscience innovation, combining expertise from biology, engineering, computer science, and medicine.
Tsinghua University has emerged as a leading institution in Alzheimer's disease (AD) research, with investigators focusing on multiple aspects of disease pathogenesis and therapy development. The university's proximity to China's large aging population provides unique opportunities for clinical research and biomarker validation.
Amyloid and Tau Biology: Researchers at Tsinghua investigate the molecular mechanisms underlying amyloid-beta ([Aβ](/proteins/amyloid-beta)) aggregation and [tau protein](/proteins/tau) pathology. Studies examine how these proteins propagate through neural circuits and develop novel therapeutic strategies to interrupt these processes [@zhang2021]. The university's engineering expertise has enabled development of advanced imaging modalities and microfluidic devices for detecting early biomarkers.
Genetic Studies in Chinese Populations: Tsinghua researchers conduct large-scale genetic studies to identify novel risk alleles for AD in Chinese populations. These studies have revealed population-specific genetic architecture that differs from European cohorts, highlighting the importance of inclusive research [@jia2020]. The university maintains collaborative registries with memory clinics across Beijing and other major Chinese cities.
Biomarker Development: Investigators are developing novel CSF and blood-based biomarkers for early diagnosis and disease monitoring. Using proteomics and metabolomics approaches, Tsinghua scientists have identified biomarker panels that may predict disease progression [@sun2022].
Therapeutic Screening: High-throughput drug screening platforms at Tsinghua evaluate compounds for disease-modifying potential. The university collaborates with pharmaceutical companies to test novel small molecules and biologics in cellular and animal models.
Parkinson's disease (PD) research at Tsinghua encompasses basic science, translational, and clinical investigations. The university has established partnerships with movement disorder clinics to access patient samples and conduct clinical studies.
Alpha-Synuclein Research: Studies on [alpha-synuclein](/proteins/alpha-synuclein) aggregation mechanisms form a cornerstone of Tsinghua's PD program. Researchers investigate how the protein misfolds, spreads between neurons, and leads to neurotoxicity [@wang2022]. Novel therapeutic approaches targeting aggregation are under development.
LRRK2 Biology: Given the importance of [LRRK2](/genes/lrrk2) mutations in both familial and sporadic PD, Tsinghua investigators study LRRK2 kinase biology and develop kinase inhibitors [@chen2021]. The university's medicinal chemistry expertise enables optimization of lead compounds for clinical development.
Neuroinflammation: Microglial activation and neuroinflammation are recognized as important contributors to PD pathogenesis. Tsinghua researchers investigate inflammatory signaling pathways and identify therapeutic targets to modulate immune responses in the brain [@liu2022].
Stem Cell Models: iPSC technology enables researchers to generate dopaminergic neurons from patient-derived cells. These models are used to study disease mechanisms and screen potential therapeutics [@zhao2023].
Neuroinflammation has emerged as a critical pathway in neurodegeneration, and Tsinghua has established robust programs investigating this process across multiple disease contexts.
Microglial Activation: Researchers study how microglia become activated in neurodegenerative conditions and how this activation contributes to neuronal dysfunction. Studies examine the role of complement proteins, pattern recognition receptors, and inflammatory cytokines [@li2021].
Therapeutic Targeting: Identification of key inflammatory pathways has enabled development of targeted interventions. Tsinghua investigators test novel anti-inflammatory compounds in models of AD, PD, and ALS.
Astrocyte Biology: Beyond microglia, astrocytes play important roles in neuroinflammation. Researchers investigate astrocyte-neuron interactions and how dysregulated astrocyte function contributes to disease.
Leveraging Tsinghua's world-leading expertise in artificial intelligence and computer science, researchers apply machine learning and computational approaches to neurodegenerative disease research.
Drug Discovery: AI models predict potential therapeutic compounds for neurodegenerative diseases, dramatically accelerating the drug discovery process [@ma2022]. Deep learning approaches analyze molecular structures and predict drug-target interactions.
Brain Network Modeling: Computational models simulate neural circuit dysfunction in disease states. These models help identify critical network nodes that may be therapeutic targets.
Big Data Analysis: Tsinghua develops algorithms for analyzing large-scale genomics, proteomics, and clinical datasets. These tools enable identification of disease patterns and biomarkers across large patient cohorts.
Mitochondrial dysfunction is a hallmark of neurodegeneration, and Tsinghua researchers investigate how impaired energy metabolism contributes to disease pathogenesis.
Metabolic Pathways: Studies examine how mitochondrial respiration is impaired in neurons and how this affects cellular energetics and survival [@fang2021].
Therapeutic Approaches: Researchers test compounds that enhance mitochondrial function and protect against oxidative stress.
Synaptic dysfunction is an early event in neurodegeneration, and Tsinghua investigates the mechanisms underlying synaptic failure.
Mechanisms of Synaptic Degeneration: Studies examine how toxic proteins disrupt synaptic function and lead to loss of synaptic connections [@yang2023].
Therapeutic Strategies: Researchers develop approaches to protect synapses and preserve neuronal connectivity.
The neurovascular unit, comprising blood vessels, neurons, and supporting cells, is increasingly recognized as important in neurodegeneration.
Blood-Brain Barrier Function: Studies examine how the blood-brain barrier is disrupted in disease and how this contributes to pathology [@he2022].
Impaired protein clearance mechanisms contribute to accumulation of toxic protein aggregates.
Autophagy Pathways: Researchers investigate autophagy dysfunction in PD and develop approaches to enhance cellular clearance mechanisms [@dong2021].
Single-cell technologies enable detailed analysis of cell types involved in neurodegeneration.
Cellular Heterogeneity: Studies using single-cell RNA sequencing reveal diverse cell populations in the brain and how they change in disease [@luo2023].
The School of Medicine houses multiple investigators focused on neurodegenerative diseases. Faculty bring expertise from diverse backgrounds including molecular biology, pharmacology, and clinical neurology.
Researchers at this institute apply genomic and computational approaches to understand disease mechanisms and develop personalized treatment strategies.
This interdisciplinary center brings together neuroscientists, engineers, and clinicians to tackle fundamental questions in brain function and disease.
Tsinghua offers comprehensive training opportunities in neuroscience and neurodegeneration research.
Tsinghua researchers investigate all aspects of AD pathogenesis, from molecular mechanisms to clinical translation. Key areas include amyloid and tau biology, neuroinflammation, biomarker development, and therapeutic discovery.
PD research spans alpha-synuclein biology, LRRK2 kinase biology, neuroinflammation, and stem cell models. The university maintains strong programs in both basic and translational research.
ALS research focuses on understanding motor neuron degeneration and developing therapeutic interventions. Studies examine TDP-43 pathology, RNA metabolism, and genetic factors [@wang2023b].
Researchers also investigate frontotemporal dementia, Huntington's disease, and other neurodegenerative conditions.
Tsinghua plays a leading role in China's Brain Project, a national initiative to map neural circuits and understand brain function. The project coordinates research efforts across multiple Chinese institutions and focuses on:
Tsinghua leads and participates in several international research consortia:
The university maintains active pharmaceutical collaborations:
Tsinghua collaborates with several clinical institutions:
The university maintains patient registries for research:
Tsinghua participates in clinical trials for:
Key capabilities include:
Advanced imaging capabilities:
The stem cell facility provides:
Tsinghua offers specialized training:
The university supports international exchange:
Support for young investigators:
Tsinghua researchers have received numerous awards:
Several challenges remain in neurodegeneration research:
Future priorities include:
Tsinghua consistently ranks among the world's top universities:
The university's research impact in neuroscience is significant: